Warning! GuruFocus detected
4 Severe warning signs
with DNA.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
New Key Statistics Module, Z-Score and F-Score
NYSE:DNA Key Ratios
Market Cap $ M | 442.80 |
Enterprise Value $ M | 358.82 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 0.58 |
Price/Sales | 1.72 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 227.00 |
EPS (TTM) $ | -10.68 |
Beneish M-Score | -2.86 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -218.90 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -0.66 |
EV-to-EBITDA | -0.74 |
PEG | -- |
Shares Outstanding M | 58.03 |
Net Margin (%) | -240.94 |
Operating Margin % | -214.82 |
Pre-tax Margin (%) | -241.15 |
Quick Ratio | 5.62 |
Current Ratio | 5.62 |
ROA % (ttm) | -35.38 |
ROE % (ttm) | -61.72 |
ROIC % (ttm) | -59.92 |
Dividend Yield % | -- |
Altman Z-Score | -6.24 |
DNA Number of Guru Trades
DNA Volume of Guru Trades
Gurus Latest Trades with NYSE:DNA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:DNA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Ginkgo Bioworks Holdings Inc Insider Transactions
No Available Data
News about NYSE:DNA
Total 0- 1